会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Complex for in-vivo target localization
    • 复杂的目标目标定位
    • US5216130A
    • 1993-06-01
    • US525258
    • 1990-05-17
    • Bruce R. LinePeter B. Weber
    • Bruce R. LinePeter B. Weber
    • A61K47/48A61K51/10A61K51/12
    • A61K51/1255A61K47/48884A61K51/1093A61K2123/00A61N5/1069
    • To localize targets within the body (i.e., fixed intravascular antigens on emboli, neovascular endothelium, endothelium altered by regional inflammation) antibodies are linked via dextran spacer arms to rapidly cleared, Tc-99m labeled, microspheres. A micron-sized, albumin microsphere has been synthesized that is designed to enhance target surface interaction and to have a high antibody loading capacity. Stable, hydrophilic microspheres are produced from a pH dependent refolding of albumin followed by heat annealing. To couple dextran, the microspheres are derivatized with succinic anhydride and then linked via carbodiimide to succinic dihydrazide. After periodate oxidized dextran forms hydrazone linkages to the microspheres, additional dihydrazide coupled to the dextran spacer arm is used to link periodate oxidized IgG via its Fc domain carbohydrate. A milligram of the resulting 0.5-1.0 micron microspheres contains 50 to 350 ug of dextran and up to 10.sup.5 covalently bound IgG molecules per microsphere. Microspheres exposed to SnCl.sub.2 can be labeled with 90 Mci/mg of Tc-99m. Spheres with high levels of dextran SDH clear the blood rapidly (T.sub.1/2 =2.6-4 min) compared to those coated with native dextran (T.sub.1/2 =35-50 min). These labelled albumin targeting microspheres may be used to detect a variety of sites of clinical interest using non-invasive external imaging devices and may be employed to carry therapeutic agents to these sites.
    • 为了使体内的靶标定位(即栓塞上的固定血管内抗原,新生血管内皮,由区域炎症改变的内皮)抗体通过葡聚糖间隔臂连接到快速清除的Tc-99m标记的微球体上。 已经合成了微米级的白蛋白微球,其被设计用于增强靶表面相互作用并具有高抗体负载能力。 稳定的亲水性微球由pH值依赖的白蛋白再折叠产生,随后进行热退火。 为了结合葡聚糖,将微球体用琥珀酸酐衍生化,然后通过碳二亚胺与琥珀酸二酰肼连接。 高碘酸氧化葡聚糖与微球形成腙键后,与葡聚糖间隔臂结合的附加二酰肼用于通过其Fc结构域碳水化合物连接高碘酸氧化的IgG。 得到的0.5-1.0微米微球的毫克每微球含有50至350μg葡聚糖和多达105个共价结合的IgG分子。 暴露于SnCl 2的微球可用90Mc / mg Tc-99m标记。 与天然葡聚糖(T1 / 2 = 35-50分钟)相比,具有高水平葡聚糖SDH的球体快速清除血液(T1 / 2 = 2.6-4分钟)。 这些标记的白蛋白靶向微球可用于使用非侵入性外部成像装置检测各种临床感兴趣的部位,并且可以用于将治疗剂携带到这些部位。
    • 2. 发明申请
    • SYSTEM AND METHOD FOR TREATING INFECTIOUS WASTE MATTER
    • 用于处理感染性废物的系统和方法
    • US20110171073A1
    • 2011-07-14
    • US13053927
    • 2011-03-22
    • Joseph H. WilsonGordon I. KayeRobert L. HahnPeter B. WeberKevin A. Morris
    • Joseph H. WilsonGordon I. KayeRobert L. HahnPeter B. WeberKevin A. Morris
    • B01J19/00
    • A62D3/35A61L2/04A61L2/18A61L2/24A61L11/00A62D2101/02A62D2101/04A62D2101/20A62D2101/28A62D2203/10B09B3/00B09B3/0075B09B3/0083G21F9/34
    • In accordance with the present invention, a system and method is provided for producing a safely disposable end product from waste matter containing undesirable materials, such as infectious, biohazardous, hazardous, or radioactive elements. The method comprises the steps of providing a highly basic solvent, immersing the waste matter containing the undesirable materials within the highly basic solvent, and heating the solvent. The waste matter containing the undesirable materials is allowed to remain within the solvent until digested, thereby forming a solution void of any infectious or biohazardous elements and/or containing a concentration of radioisotope below the maximum permissible concentration (MPC) for release to a sanitary sewer as defined in applicable federal regulations. The invention further provides a system for producing a safely disposable end product void of any infectious or biohazardous elements and/or containing only a concentration of radioisotope below the MPC for release to a sanitary sewer as defined in applicable federal regulations from waste matter containing such materials. The system comprises a tank or vessel capable of containing a highly basic solvent during a closed digestion reaction, heating means for heating the solvent within the vessel, filtering means, and means for removing the post-digestion aqueous solution and solid waste materials from within the vessel. The post-digestion product in both aqueous and solid form can then by disposed of by conventional means.
    • 根据本发明,提供了一种系统和方法,用于从含有不希望的材料(例如感染性,生物危害性的,危险的或放射性的)元素的废物中产生安全的一次性最终产品。 该方法包括提供高碱性溶剂,将含有不需要的物质的废物浸入高碱性溶剂中并加热溶剂的步骤。 允许含有不需要的材料的废物保留在溶剂中直到消化,从而形成无法感染或生物危害的元素的溶液和/或含有低于最大允许浓度(MPC)的放射性同位素浓度以释放到卫生污水管 如适用的联邦法规所定义。 本发明还提供了一种用于生产无任何传染性或生物危害元素的安全的一次性终端产品和/或仅在MPC下方仅含有放射性同位素浓度的系统,用于根据适用的联邦法规从含有这种材料的废物中定义的卫生下水道 。 该系统包括能够在封闭的消化反应期间容纳高碱性溶剂的罐或容器,用于加热容器内的溶剂的加热装置,过滤装置和用于从消化反应器内部除去消化后水溶液和固体废物的装置 船只。 然后可以通过常规方法处理水和固体形式的消化后产物。
    • 5. 发明授权
    • Method for disposing of radioactively labeled animal carcasses
    • 处理放射性标记动物尸体的方法
    • US5332532A
    • 1994-07-26
    • US988209
    • 1992-12-09
    • Gordon I. KayePeter B. Weber
    • Gordon I. KayePeter B. Weber
    • G21F9/28G21F9/32G21F9/16
    • G21F9/28G21F9/32
    • A method for disposing of animal tissue containing radioactive materials by producing a solution containing a substantially de minimis concentration of radioactive materials through alkaline hydrolysis and dilution of the animal tissue containing the radioactive materials followed by disposing of the de minimis solution in a sewage system or septic system. Additionally, an apparatus for practicing the above method which comprises a tank capable of forming a closed reaction vessel with a highly basic solvent therein. The apparatus further comprises a means for heating the highly basic solvent and means for filtering and removing the solution of de minimis radioactivity formed within the tank.
    • 通过生产含有基本上最小浓度的放射性物质的溶液,通过碱性水解和稀释含有放射性物质的动物组织,然后将微量溶液处理在污水系统或化粪池中来处理含有放射性物质的动物组织的方法 系统。 另外,用于实施上述方法的装置包括能够形成其中具有高碱性溶剂的封闭反应容器的罐。 该装置还包括用于加热高碱性溶剂的装置和用于过滤和除去在罐内形成的最小放射性溶液的装置。
    • 10. 发明授权
    • Methods for treatment and disposal of regulated medical waste
    • 治疗和处置受管制医疗废物的方法
    • US06437211B2
    • 2002-08-20
    • US09882806
    • 2001-06-14
    • Gordon I. KayePeter B. Weber
    • Gordon I. KayePeter B. Weber
    • A61L218
    • A61L11/00B09B3/0075
    • A method for safely treating and disposing of infectious biomedical waste and other hazardous materials is disclosed. The method involves alkaline hydrolysis of infectious agents contained in regulated medical waste or hazardous waste solutions. The infectious waste is immersed into a highly basic solvent (>130° C.,>2.79 atm) until the hydrolyzable matter is fully digested, thereby forming a sterile solution and sterile solid waste. The sterile solution and solid waste may then be disposed of through standard means, such as in a sanitary sewage system or local landfill facility. The method also provides for the treatment of lipid soluble hazardous material contained in the regulated medical waste.
    • 公开了一种用于安全处理和处理感染性生物医学废物和其他有害物质的方法。 该方法包括对受规管医疗废物或危险废物溶液中含有的感染因子的碱性水解。 将感染性废物浸入高碱性溶剂(> 130℃,> 2.79大气压)中直至水解物完全消化,从而形成无菌溶液和无菌固体废物。 然后,无菌溶液和固体废物可以通过标准方法处理,例如在生活污水系统或当地垃圾填埋场。 该方法还提供了治疗受监管医疗废物中含有的脂溶性有害物质。